[{"Assets_0_Q2_USD":15117556000.0,"EarningsPerShareBasic_1_Q2_USD":30.71,"EarningsPerShareBasic_2_Q2_USD":63.49,"EarningsPerShareDiluted_1_Q2_USD":30.32,"EarningsPerShareDiluted_2_Q2_USD":62.7,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":268234000.0,"NetIncomeLossConverted_1_Q2_USD":914114000.0,"NetIncomeLossConverted_2_Q2_USD":1891528000.0,"RevenuesConverted_1_Q2_USD":715931000.0,"RevenuesConverted_2_Q2_USD":1442727000.0,"StockholdersEquity_0_Q2_USD":11594880000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":30148000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":30167000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29793000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29764000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20210730"}]